Clinical Trial Update: Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating the effectiveness and immune response of IL-2 therapy in patients with hepatitis C virus–associated cryoglobulinemic vasculitis; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cryoglobulinemic Vasculitis

Drugs mentioned

• Proleukin (aldesleukin)

Snippet

Sponsor: French National Agency for Research on AIDS and Viral Hepatitis | Conditions: Cryoglobulinemia Vasculitis | Phase 1, Phase 2 | Status: COMPLETED